Grab a drink, attend a talk, meet other innovators, and make things happen.
Thursday, November 21, 2019
4:30 – 5:30 p.m.
@4240 Duncan Avenue
Havana Room, 2nd Floor
The Institute of Clinical and Translational Sciences (ICTS) Precision Medicine team invites you to an on-going collaboration with Venture Café. These sessions will be hosted on the third Thursday of every month in the @4240 building.
Maintaining Brain Circuits: New Therapeutic Strategies for Neurodegenerative Disease
Aaron DiAntonio, MD, PhD, Alan A and Edith L Wolff Professor of Developmental Biology
Ancient conflicts: Modern Uses for a Primordial Immune System
Jeffrey Milbrandt, MD, PhD, James S. McDonnell Professor and Chair, Department of Genetics
Our discovery of a new family of metabolic enzymes and their role in maintaining neural circuitry has led to new therapeutic targets for neurodegenerative disease. Their origins as early tools in the battle between bacteria and viruses identifies these enzymes as components of a primordial immune system. Exploiting this discovery has implications for neurodegeneration, bacterial infections, and plant resistance. To translate these discoveries into treatments for neurodegenerative diseases, we established the Center for Neurometabolism and Axonal Therapeutics with a gift from Phil and Sima Needleman and co-founded Disarm Therapeutics with Atlas Ventures.
For more information visit the ICTS Precision Medicine website.